Response to Damiani and colleagues

Ann Intensive Care. 2020 Oct 14;10(1):140. doi: 10.1186/s13613-020-00757-6.

J-L Diehl^{1

2

3}, N Peron⁴, A Philippe^{5

6

7}, D M Smadja^{5

6

7}

¹ Université de Paris, Innovative Therapies in Haemostasis, INSERM, 75006, Paris, France. [email protected].
² Biosurgical Research Lab (Carpentier Foundation), 20 rue Leblanc, AH-HP, Georges Pompidou European Hospital, 75015, Paris, France. [email protected].
³ Medical Intensive Care Unit, AH-HP, Georges Pompidou European Hospital, 20 rue Leblanc, 75015, Paris, France. [email protected].
⁴ Medical Intensive Care Unit, AH-HP, Georges Pompidou European Hospital, 20 rue Leblanc, 75015, Paris, France.
⁵ Université de Paris, Innovative Therapies in Haemostasis, INSERM, 75006, Paris, France.
⁶ Biosurgical Research Lab (Carpentier Foundation), 20 rue Leblanc, AH-HP, Georges Pompidou European Hospital, 75015, Paris, France.
⁷ Hematology Department, AH-HP, Georges Pompidou European Hospital, 75015, Paris, France.

No abstract available

Publication types